| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.17 | 5e-08 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.18 | 3e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.12 | 6e-05 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |